Malaria remains the most significant health risk for visitors to East Africa — Plasmodium falciparum malaria (the most severe form) is endemic across Uganda, Tanzania, coastal Kenya, and most of Rwanda at lower altitudes. The good news: malaria is highly preventable with the combination of appropriate chemoprophylaxis (anti-malaria medication), insect repellent, and bed nets where required. Understanding which medications are available, which are appropriate for your itinerary, and what the actual risk level is across specific East Africa destinations allows you to make an informed decision about your prevention approach. This 2025 guide covers malaria prevention for the complete East Africa safari circuit.
Risk Zones by Country and Altitude
Malaria risk is not uniform across East Africa — altitude is the critical variable, as the Anopheles mosquito that transmits Plasmodium falciparum cannot complete its life cycle above approximately 2,000–2,500m altitude due to temperature constraints. Risk levels:
- High risk: Uganda lowlands (Murchison Falls, Lake Victoria shores, Albert Nile areas), Tanzania coast (Dar es Salaam, Zanzibar, Selous, Tarangire at low altitude), coastal Kenya (Mombasa, Watamu, Malindi), Rwanda lowlands (Akagera, Rusizi area)
- Moderate risk: Uganda western highlands (Kibale, Queen Elizabeth at 900–1,100m), Kenya highlands below 1,800m (Naivasha, Nakuru, Mara at 1,650m), Tanzania northern highlands (Arusha at 1,400m, Ngorongoro rim at 2,300m — lower risk but not zero)
- Low to negligible risk: Rwanda highlands above 2,000m (Kigali at 1,567m — low but present; Volcanoes NP base at 2,400m — very low), Kenya above 2,000m (Nairobi CBD at 1,661m — low, but the surrounding lowlands including Mombasa road are higher risk)
Chemoprophylaxis Options Compared
Atovaquone-Proguanil (Malarone)
Malarone is the current first-line recommendation for most East Africa visitors. Dosing: 1 tablet daily, beginning 1–2 days before entering a malaria zone and continuing for 7 days after leaving. Advantages: very high efficacy against P. falciparum, taken daily so it leaves the body quickly after stopping (useful for short trips), well-tolerated by most people, no weekly dosing confusion. Side effects: nausea in 5–10% of users (take with food to reduce), occasional vivid dreams, rare serious reactions. Cost: approximately USD $3–5 per tablet in the US/UK — expensive for long trips (8 weeks = 63 tablets). In East Africa, Malarone generics are available at pharmacies in Kampala, Nairobi, and Kigali for approximately USD $0.50–1.00 per tablet — confirm authenticity with a reputable pharmacy chain (Aga Khan pharmacies in Kenya, Quality Chemical in Uganda). Recommended for: first-time visitors, short trips (1–3 weeks), visitors with concerns about the side-effect profiles of alternatives.
Doxycycline
Doxycycline is a broad-spectrum antibiotic taken daily that also provides malaria prophylaxis. Dosing: 100mg daily, beginning 1–2 days before entering the malaria zone and continuing for 28 days after leaving. Advantages: inexpensive (USD $0.10–0.30 per tablet), widely available, also provides some protection against traveller’s diarrhoea caused by bacteria. Disadvantages: photosensitivity (sun sensitivity — users burn more easily, an important consideration for open-top game drives in the East Africa sun; wear high-SPF sunscreen and sun-protective clothing consistently). Should be taken with plenty of water and not immediately before lying down (risk of oesophageal irritation). Cannot be taken by pregnant women or children under 8. Recommended for: visitors on a budget, long-trip travellers (4+ weeks), divers (Malarone has some interaction with scuba diving at depth — discuss with a dive physician).
Mefloquine (Lariam)
Mefloquine is taken weekly (once per week) rather than daily — convenient for long trips. However, mefloquine has a documented side-effect profile that includes vivid dreams, sleep disturbance, anxiety, and in a small percentage of users, more serious neuropsychiatric effects. The US FDA issued a black box warning on mefloquine in 2013. Most travel medicine physicians now recommend Malarone or Doxycycline over mefloquine for first-choice prophylaxis unless there are specific reasons (weekly dosing preference, cost constraints, drug interactions). Begin mefloquine 2 weeks before entering the malaria zone (allows side effects to be assessed before arrival). Not recommended for: visitors with history of depression, anxiety disorder, seizures, or psychosis; pilots and professional drivers.
Physical Prevention: The Equal Half
Chemoprophylaxis reduces but does not eliminate malaria risk — the combination of medication plus physical prevention measures is significantly more effective than either alone. Physical prevention for East Africa:
- DEET repellent (50%+): Apply to all exposed skin at dawn (05:30–08:00) and dusk (17:30–20:00) — the primary Anopheles mosquito feeding windows. Reapply every 4 hours in high-humidity conditions.
- Long sleeves and trousers at dusk: The most underutilised prevention measure — simply covering skin eliminates a large proportion of the exposure risk at the highest-risk hour.
- Bed net: Essential in basic accommodation (guesthouses, budget lodges, camping). High-end safari lodges in East Africa uniformly provide bed nets or use sealed rooms with air conditioning — confirm before booking if this is a priority.
- Permethrin treatment: Spray clothing and bed nets with permethrin (an insecticide that bonds to fabric and remains effective through multiple washes) — dramatically reduces mosquito landing on treated fabric.
If Symptoms Develop
Malaria symptoms (fever, chills, headache, muscle ache, nausea) typically appear 7–30 days after a potentially infectious bite. If you develop a fever during or after an East Africa trip, seek medical evaluation immediately — a blood smear or rapid diagnostic test (RDT) confirms or rules out malaria within 20–30 minutes at any competent clinic. Do not wait to see if symptoms resolve. Treatment: artemisinin-based combination therapy (ACT) — Coartem (artemether-lumefantrine) is the standard first-line treatment throughout East Africa, effective against all P. falciparum strains. Treatment is highly effective when started promptly — delayed treatment is the primary cause of severe malaria complications. In Nairobi, the Aga Khan Hospital and MP Shah Hospital provide reliable malaria diagnosis and treatment. In Kampala, Nakasero Hospital and International Hospital Kampala. In Kigali, King Faisal Hospital.